This episode explores how pharmaceutical engagement will evolve as AI increasingly becomes the first port of call for HCPs to access medical information and guidelines. Learn how investments must shift as share of algorithmic trust becomes a key battleground, and how in-field roles will need to evolve to provide deeper, more consultative engagements.